W Strategies, LLC
$26.8M
Total Income
37
Clients
1
Lobbyists
595
Filings
Income by Year
| Year | Lobbying Income |
|---|---|
| 2018 | $3.2M |
| 2019 | $3.1M |
| 2020 | $3.3M |
| 2021 | $3.8M |
| 2022 | $4.2M |
| 2023 | $3.7M |
| 2024 | $3.0M |
| 2025 | $2.6M |
Clients
Merck & Co., INC.Supernus Pharmaceuticals FKA Sage Therapeutics23andme, INC.Abbott LaboratoriesAbbvie INC.Actelion Pharmaceuticals US, INCAlexion PharmaceuticalsAstrazeneca Pharmaceuticals LPBiogenCalifornia Life SciencesConsumer Healthcare Products AssociationEnovisGlaxosmithklineIpsen Biopharmaceuticals, INC.Juul Labs INCMedtronic, INC.Mckesson CorporationPharmaceutical Research and Manufacturers of AmericaSanofi U.S. Services, INC.United Services Automobile Association (Usaa)Global Blood TherapeuticsTesaro, INC.Gilead Sciences, INC.Moderna, INC.Incyte CorporationSecure Identity, LLCIovance Biotherapeutics, INC.Vir Biotechnology, INC.Thermo Fisher Scientific INCKaruna TherapeuticsStoke TherapeuticsDelfi DiagnosticsOtsuka America Pharmaceutical, INC.Phlow Corp.Alveo TechnologiesElevatebioPaperbirch Strategies on Behalf of Ap3 Biomedical
Lobbyists
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.